Roland Martin

Sitert av

	Alle	Siden 2019
Sitater	45356	13074
h-indeks	100	47
i10-indeks	337	185

2600

1300

650

1950

19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024196 183 261 373 490 680 830 720 943 899 910 1078 1288 1255 1429 1507 1402 1548 1550 1815 2067 2062 2148 2104 2047 1838 2046 2155 2522 2309 2129 1878

Offentlig tilgang

Vis alle

91 artikler

5 artikler

tilgjengelige

ikke tilgjengelige

Basert på finansieringsmandater

Medforfattere

Bruno GranConsultant Neurologist and Honorary Professor of Neurology - NUH NHS TrustVerifisert e-postadresse på nuh.nhs.uk
Xavier MontalbanVerifisert e-postadresse på cem-cat.org
Richard SimonR Simon Consulting, Formerly Chief, Computational & Systems Biology, National Cancer InstituteVerifisert e-postadresse på mail.nih.gov
Jan D. LunemannUniversity of ZurichVerifisert e-postadresse på uzh.ch
Yingdong ZhaoNational Cancer InstituteVerifisert e-postadresse på mail.nih.gov
Christian MünzInstitute of Experimental Immunology, University of ZurichVerifisert e-postadresse på immunology.uzh.ch
lawrence steinmanstanford universityVerifisert e-postadresse på stanford.edu
Friedemann PaulProfessor für klinische Neuroimmunologie, Charité Universitätsmedizin BerlinVerifisert e-postadresse på charite.de
Eric O. LongNational Institute of Allergy and Infectious DiseasesVerifisert e-postadresse på nih.gov
Nadja KadomEmory University and Children's of AtlantaVerifisert e-postadresse på emory.edu
Jordi RioServicio de Neurologia-Neuroinmunologia. Centro de esclerosis múltiple de Catalunya. Hospital Universitario Vall d'HebronVerifisert e-postadresse på cem-cat.org
Maria Pia SormaniUniversity of GenoaVerifisert e-postadresse på unige.it
Lael StoneAssociate professor of neurology, Lerner college of medicine of the Cleveland clinic at case western university school of medicineVerifisert e-postadresse på ccf.org
Marco PrinzProfessor of Neuropathology, University Hospital FreiburgVerifisert e-postadresse på uniklinik-freiburg.de
Claude C BernardEmeritus Professor, Australian Regenerative Medicine Institute, Monash University, MelbourneVerifisert e-postadresse på monash.edu
Alexander U. BrandtEli Lilly and CompanyVerifisert e-postadresse på lilly.com
Paul S AlbertNational Cancer InstituteVerifisert e-postadresse på mail.nih.gov
Michael RackeProfessor of Neurology, Ohio State UniversityVerifisert e-postadresse på osumc.edu
Axel PetzoldUniversity College London, The National Hospital for Neurology and Neurosurgery & Moorfields EyeVerifisert e-postadresse på ucl.ac.uk
Jose Carlos Alvarez-CermeñoRamón y Cajal Research Institute. Madrid. SpainVerifisert e-postadresse på salud.madrid.org

Følg

Roland Martin

University Zurich

Verifisert e-postadresse på usz.ch

multiple sclerosis cellular immunology neuroimmunology T lymphocytes neurology


Tittel Sorter etter sitater Sorter etter år Sorter etter tittel	Sitert av Sitert av	År
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 (7359), 214-219, 2011	3068	2011
Immunology of multiple sclerosis M Sospedra, R Martin Annu. Rev. Immunol. 23 (1), 683-747, 2005	3017	2005
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013	1371	2013
Immunological aspects of demyelinating diseases R Martin, HF McFarland, DE McFarlin Annual review of immunology 10 (1), 153-187, 1992	1350	1992
Multiple sclerosis: a complicated picture of autoimmunity HF McFarland, R Martin Nature immunology 8 (9), 913-919, 2007	1340	2007
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019	1023	2019
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand B Bielekova, B Goodwin, N Richert, I Cortese, T Kondo, G Afshar, B Gran, ... Nature medicine 6 (10), 1167-1175, 2000	998	2000
Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis B Bielekova, M Catalfamo, S Reichert-Scrivner, A Packer, M Cerna, ... Proceedings of the National Academy of Sciences 103 (15), 5941-5946, 2006	733	2006
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis R Martin, HF McFarland, JM Boggs Critical reviews in clinical laboratory sciences 32 (2), 121-182, 1995	686	1995
TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways I Štefanová, B Hemmer, M Vergelli, R Martin, WE Biddison, RN Germain Nature immunology 4 (3), 248-254, 2003	574	2003
The OSCAR-IB consensus criteria for retinal OCT quality assessment P Tewarie, L Balk, F Costello, A Green, R Martin, S Schippling, A Petzold PloS one 7 (4), e34823, 2012	567	2012
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients PA Muraro, DC Douek, A Packer, K Chung, FJ Guenaga, ... The Journal of experimental medicine 201 (5), 805-816, 2005	559	2005
Memory B cells activate brain-homing, autoreactive CD4+ T cells in multiple sclerosis I Jelcic, F Al Nimer, J Wang, V Lentsch, R Planas, I Jelcic, A Madjovski, ... Cell 175 (1), 85-100. e23, 2018	469	2018
Exploring the origins of grey matter damage in multiple sclerosis M Calabrese, R Magliozzi, O Ciccarelli, JJG Geurts, R Reynolds, R Martin Nature Reviews Neuroscience 16 (3), 147-158, 2015	462	2015
Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis HF McFarland, JA Frank, PS Albert, ME Smith, R Martin, JO Harris, ... Annals of neurology 32 (6), 758-766, 1992	454	1992
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system M Prinz, H Schmidt, A Mildner, KP Knobeloch, UK Hanisch, J Raasch, ... Immunity 28 (5), 675-686, 2008	448	2008
Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein S Brocke, K Gijbels, M Allegretta, I Ferber, C Piercy, T Blankensteini, ... Nature 379 (6563), 343-346, 1996	437	1996
The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis N Sommer, PA Löschmann, GH Northoff, M Weller, A Steinbrecher, ... Nature medicine 1 (3), 244-248, 1995	436	1995
Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. R Martin, D Jaraquemada, M Flerlage, J Richert, J Whitaker, EO Long, ... Journal of immunology (Baltimore, Md.: 1950) 145 (2), 540-548, 1990	432	1990
Development of biomarkers in multiple sclerosis B Bielekova, R Martin Brain 127 (7), 1463-1478, 2004	411	2004

Systemet kan ikke utføre handlingen. Prøv på nytt senere.

Artikler 1–20

Sitater per år

Duplikatsitater

Sammenslåtte sitater

Legg til medforfattereMedforfattere

Følg

Sitert av

Medforfattere